ALL vs CLRB · P/E 4.9, $56.89B cap vs $20.8M cap
The Allstate Corporation (ALL) versus Cellectar Biosciences Inc (CLRB) — a side-by-side from cached financials, not a winner call.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
Cellectar Biosciences Inc (CLRB) is a biotechnology company listed on US.
ALL does not have a complete income-statement cache yet.
CLRB does not have a complete income-statement cache yet.
ALL currently screens at market cap $56.89B and trailing P/E 4.9. CLRB currently screens at market cap $20.8M.
Not investment advice. Open the ALL and CLRB stock pages for the full models.
Not investment advice.